Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Constipation Management Guidelines

Initial Management

  • The American Gastroenterological Association recommends discontinuing all medications that can cause constipation when feasible before further evaluation 1, 2, 3
  • Ensure privacy and comfort for normal defecation, use positioning aids like footstools to assist gravity, and increase fluid intake and physical activity within patient limits, as suggested by the Annals of Oncology 4
  • Educate patients to attempt defecation at least twice daily, preferably 30 minutes after meals, straining no more than 5 minutes, according to the Annals of Oncology 4
  • Start with osmotic laxatives (polyethylene glycol 17g daily, lactulose, or magnesium salts) OR stimulant laxatives (senna, bisacodyl, glycerol suppositories) as first-line pharmacologic therapy, recommended by Gastroenterology 1, 4, 3

Diagnostic Testing

  • Perform anorectal testing only in patients who do not respond to the initial therapeutic trial, as recommended by Gastroenterology 1, 2
  • Conduct a careful digital rectal examination including assessment of pelvic floor motion during simulated evacuation before referral for anorectal manometry, suggested by Gastroenterology 3
  • A normal digital rectal examination does NOT exclude defecatory disorders, according to Gastroenterology 3

Second-Line Therapy

  • When symptoms do not respond to simple laxatives, consider newer agents like linaclotide or lubiprostone, recommended by Gastroenterology 1, 2, 3
  • Linaclotide increases complete spontaneous bowel movements by approximately 1.5 per week compared to placebo, although the exact citation is not provided, a similar fact is mentioned in Nature Reviews Gastroenterology and Hepatology 5
  • Secretagogues like linaclotide soften stools and accelerate gut transit by activating ion channels on enterocytes, as described in Nature Reviews Gastroenterology and Hepatology 5

Treatment Based on Constipation Subtype

  • Pelvic floor retraining by biofeedback therapy rather than laxatives is the treatment of choice for defecatory disorders, recommended by Gastroenterology 1, 2, 6
  • Biofeedback therapy improves symptoms in more than 70% of patients with defecatory disorders, according to Gastroenterology 1, 2
  • Normal transit constipation (NTC) and slow transit constipation (STC) can be safely managed with long-term use of laxatives, suggested by Gastroenterology 1, 2

Surgical Options

  • Surgery is indicated only after failure of an aggressive, prolonged trial of laxatives, fiber, and prokinetic agents, and only in well-documented slow transit constipation, recommended by Gastroenterology 1, 2, 6
  • Total colectomy with ileorectal anastomosis is the procedure of choice, according to Gastroenterology 1, 2, 6
  • Must exclude coexistent upper gastrointestinal motility disorders and defecatory disorders before surgery, as suggested by Gastroenterology 1, 2, 6

Critical Pitfalls to Avoid

  • Do not perform extensive metabolic testing or colonoscopy without alarm features or appropriate screening indications, recommended by Gastroenterology 3
  • Do not use bulk laxatives in opioid-induced constipation or in non-ambulatory patients with low fluid intake, according to the Annals of Oncology 4
  • Do not proceed to surgery without excluding defecatory disorders and upper GI motility disorders, recommended by Gastroenterology 1, 2, 6
  • Do not skip biofeedback therapy in patients with defecatory disorders—it is more effective than laxatives, suggested by Gastroenterology 1, 2, 6